Axa’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-55,656
| Closed | -$6.6M | – | 1260 |
|
|
2022
Q1 | $6.6M | Sell |
55,656
-5,391
| -9% | -$639K | 0.02% | 573 |
|
|
2021
Q4 | $8.41M | Buy |
61,047
+8,656
| +17% | +$1.19M | 0.02% | 540 |
|
|
2021
Q3 | $7.28M | Buy |
52,391
+10,460
| +25% | +$1.45M | 0.02% | 582 |
|
|
2021
Q2 | $4.07M | Sell |
41,931
-3,185
| -7% | -$309K | 0.01% | 755 |
|
|
2021
Q1 | $3.08M | Buy |
45,116
+821
| +2% | +$56.1K | 0.01% | 780 |
|
|
2020
Q4 | $3.8M | Sell |
44,295
-23,809
| -35% | -$2.04M | 0.01% | 747 |
|
|
2020
Q3 | $4.43M | Sell |
68,104
-657
| -1% | -$42.7K | 0.02% | 660 |
|
|
2020
Q2 | $5.03M | Buy |
68,761
+4,148
| +6% | +$303K | 0.02% | 610 |
|
|
2020
Q1 | $2.2M | Buy |
+64,613
| New | +$2.2M | 0.01% | 713 |
|
|
2018
Q1 | – | Sell |
-130,484
| Closed | -$3.52M | – | 1468 |
|
|
2017
Q4 | $3.52M | Buy |
+130,484
| New | +$3.52M | 0.01% | 739 |
|